Multiple recombinant adeno-associated viral vector serotypes display persistent in vivo gene expression in vector-transduced rat stifle joints

Human Gene Therapy Methods

Volumn 24, Issue 3, 2013, Pages 185-194

  Mason, Jeffrey B ^a   Gurda, Brittney L ^a   Engiles, Julie B ^a   Hankenson, Kurt D ^a   Wilson, James M ^a   Richardson, Dean W ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; LUCIFERIN; PARVOVIRUS VECTOR; SURFACTANT;

ADENO ASSOCIATED VIRUS; ADIPOCYTE; ANIMAL EXPERIMENT; ARTICLE; BIOLUMINESCENCE; CARTILAGE CELL; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOMEGALOVIRUS; FIBROBLAST; GENE EXPRESSION; HINDLIMB; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO GENE TRANSFER; JOINT; JOINT CAPSULE; LONGEVITY; MACROPHAGE; MARKER GENE; MESENCHYME CELL; MONOLAYER CULTURE; MUSCLE CELL; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; PROMOTER REGION; RAT; SEROTYPE; SYNOVIOCYTE; TRANSGENE; TROPISM; VIRUS RECOMBINANT;

ANIMALS; DEPENDOVIRUS; GENE EXPRESSION; GENETIC THERAPY; GENETIC VECTORS; LUCIFERASES; MALE; PROMOTER REGIONS, GENETIC; RATS; RATS, SPRAGUE-DAWLEY; SEROTYPING; STIFLE; SURFACE-ACTIVE AGENTS; TRANSDUCTION, GENETIC;

CYTOMEGALOVIRUS; RATTUS;

EID: 84879384199     PISSN: 19466536     EISSN: 19466544     Source Type: Journal    
DOI: 10.1089/hgtb.2012.199     Document Type: Article

References (42)

1. Allocca, M., Mussolino, C., Garcia-Hoyos, M., et al. (2007). Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors. J. Virol. 81, 11372-11380. (Pubitemid 47536108)
2. Auricchio, A., Hildinger, M., O'Connor, E., et al. (2001). Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column. Hum. Gene Ther. 12, 71-76. (Pubitemid 32044468)
3. Bell, C.L., Vandenberghe, L.H., Bell, P., et al. (2011). The AAV9 receptor and its modification to improve in vivo lung gene transfer in mice. J. Clin. Invest. 121, 2427-2435.
4. Bennicelli, J., Wright, J.F., Komaromy, A., et al. (2008). Reversal of blindness in animal models of Leber congenital amaurosis using optimized AAV2-mediated gene transfer. Mol. Ther. 16, 458-465. (Pubitemid 351314983)
5. Boutin, S., Monteilhet, V., Veron, P., et al. (2010). Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: Implications for gene therapy using AAV vectors. Hum. Gene Ther. 21, 704-712.
6. Chen, C.C., Sun, C.P., Ma, H.I., et al (2009). Comparative study of anti-hepatitis B virus RNA interference by double-stranded adeno-associated virus serotypes 7, 8, and 9. Mol. Ther. 17, 352-359.
7. Cottard, V., Valvason, C., Falgarone, G., et al. (2004). Immune response against gene therapy vectors: Influence of synovial fluid on adeno-associated virus mediated gene transfer to chondrocytes. J. Clin. Immunol. 24, 162-169. (Pubitemid 38457230)
8. Evans, C.H., Gouze, E., Gouze, J.N., et al. (2006). Gene therapeutic approaches-transfer in vivo. Adv. Drug Deliv. Rev. 58, 243-258.
9. Fechner, H., Sipo, I., Westermann, D., et al. (2008). Cardiactargeted RNA interference mediated by an AAV9 vector improves cardiac function in coxsackievirus B3 cardiomyopathy. J. Mol. Med. 86, 987-997.
10. Fraenkel, L., Bogardus, S.T., Concato, J., and Wittink, D.R. (2004). Treatment options in stifle osteoarthritis - the patient's perspective. Arch. Intern. Med. 164, 1299-1304. (Pubitemid 38828880)
11. Gao, G.P., Alvira, M.R., Wang, L.L., et al. (2002). Novel adenoassociated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. U. S. A. 99, 11854-11859. (Pubitemid 34994488)
12. Goater, J., Muller, R., Kollias, G., et al. (2000). Empirical advantages of adeno associated viral vectors for in vivo gene therapy for arthritis. J. Rheumatol. 27, 983-989. (Pubitemid 30389758)
13. Gouze, E., Gouze, J.N., Palmer, G.D., et al. (2007). Transgene persistence and cell turnover in the diarthrodial joint: Implications for gene therapy of chronic joint diseases. Mol. Ther. 15, 1114-1120. (Pubitemid 46813614)
14. Hildinger, M., Auricchio, A., Gao, G., et al. (2001). Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle- directed gene transfer. J. Virol. 75, 6199-6203. (Pubitemid 32553151)
15. Hung, G.L., Galealauri, J., Mueller, G.M., et al. (1994). Suppression of intraarticular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium. Gene Ther. 1, 64-69.
16. Hunter, D.J., and Felson, D.T. (2006). Osteoarthritis. Br. Med. J. 332, 639-642B. (Pubitemid 44365719)
17. Inoue, Y., Kiryu, S., Izawa, K., et al. (2009). Comparison of subcutaneous and intraperitoneal injection of d-luciferin for in vivo bioluminescence imaging. Eur. J. Nucl. Med. Mol. Imaging 36, 771-779.
18. Inoue, Y., Kiryu, S., Watanabe, M., et al. (2010). Timing of imaging after d-luciferin injection affects the longitudinal assessment of tumor growth using in vivo bioluminescence imaging. Int. J. Biomed. Imaging 8, 1-6.
19. Jiang, X.F., Burdorf, L., Hinkel, R., et al. (2009). Optimization of delivery of adeno-associated virus mediated gene transfer to a transplanted heart in a rat model. Exp. Clin. Transplant. 7, 184-187.
20. Kaklamanis, P.M. (1992). Experimental animal models resembling rheumatoid arthritis. Clin. Rheumatol. 11, 41-47.
21. Keswani, S.G., Balaji, S., Le, L., et al. (2012). Pseudotyped adenoassociated viral vector tropism and transduction efficiencies in murine wound healing. Wound Repair Regen. 20, 592-600.
22. Khoury, M., Bigey, P., Louis-Plence, P., et al. (2006). A comparative study on intra-articular versus systemic gene electrotransfer in experimental arthritis. J. Gene Med. 8, 1027-1036. (Pubitemid 44282999)
23. Koo, T., Malerba, A., Athanasopoulos, T., et al. (2011). Delivery of AAV2/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of alpha 1-syntrophin and alpha-dystrobrevin in skeletal muscles of mdx mice. Hum. Gene Ther. 22, 1379-1388.
24. Kotchey, N.M., Adachi, K., Zahid, M., et al. (2011). A potential role of distinctively delayed blood clearance of recombinant adeno-associated virus serotype 9 in robust cardiac transduction. Mol. Ther. 19, 1079-1089.
25. Luo, X.Y., Hall, G., Li, S.T., et al. (2011). Hepatorenal correction in murine glycogen storage disease type i with a doublestranded adeno-associated virus vector. Mol. Ther. 19, 1961-1970.
26. Manno, C.S., Arruda, V.R., Pierce, G.F., et al. (2006). Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response. Nat. Med. 12, 342-347. (Pubitemid 43355084)
27. Mason, J.B., Vandenberghe, L.H., Xiao, R., et al. (2012). Transduction efficiency of recombinant adeno-associated viral vectors is differentially influenced by vector serotype and tissue composition in equine synovial joint tissues. Am. J. Vet. Res. 73, 1178-1185.
28. Mattar, C.N., Nathwani, A., Rosales, C., et al. (2012). Early AAVmediated intrauterine gene therapy at 0.4G in non-human primates. Mol. Ther. 20, S252-S253.
29. Pan, R.Y., Xiao, X., Chen, S.L., et al. (1999). Disease-inducible transgene expression from a recombinant adeno- associated virus vector in a rat arthritis model. J. Virol. 73, 3410-3417. (Pubitemid 29135734)
30. Payne, K.A., Lee, H.H., Haleem, A.M., et al. (2011). Single intraarticular injection of adeno-associated virus results in stable and controllable in vivo transgene expression in normal rat stifles. Osteoarthritis Cartilage 19, 1058-1065.
31. Pfeifer, C., Aneja, M.K., Hasenpusch, G., et al. (2011). Adenoassociated virus serotype 9-mediated pulmonary transgene expression: Effect of mouse strain, animal gender and lung inflammation. Gene Ther. 18, 1034-1042.
32. Pulicherla, N., Shen, S., Yadav, S., et al. (2011). Engineering liverdetargeted AAV9 vectors for cardiac and musculoskeletal gene transfer. Mol. Ther. 19, 1070-1078.
33. Rahim, A.A., Wong, A.M.S., Hoefer, K., et al. (2011). Intravenous administration of AAV2/9 to the fetal and neonatal mouse leads to differential targeting of CNS cell types and extensive transduction of the nervous system. FASEB J. 25, 3505-3518.
34. Remmers, E.F., Lafyatis, R., Kumkumian, G.K., et al. (1990 Cytokines and growth regulation of synoviocytes from patients with rheumatoid arthritis and rats with streptococcal cell wall arthritis. Growth Factors 2, 179-188. (Pubitemid 20057755)
35. Roessler, B.J., and Davidson, B.L. (1993). Genetic modification of synoviocytes in vivo using recombinant adenoviral vectors. Clin. Res. 41, A171.
36. Saraf, A., and Mikos, A.G. (2006). Gene delivery strategies for cartilage tissue engineering. Adv. Drug Deliv. Rev. 58, 592-603. (Pubitemid 43928174)
37. Tenenbaum, L., Lehtonen, E., and Monahan, P.E. (2003). Evaluation of risks related to the use of adeno-associated virusbased vectors. Curr. Gene Ther. 3, 545-565.
38. Walker-Bone, K., Javaid, K., Arden, N., and Cooper, C. (2000). Regular review - medical management of osteoarthritis. Br. Med. J. 321, 936-940.
39. Wang, L., Louboutin, J.P., Bell, P., et al. (2011). Muscle-directed gene therapy for hemophilia B with more efficient and less immunogenic AAV vectors. J. Thromb. Haemost. 9, 2009-2019.
40. Xiao, X., Li, J., and Samulski, R.J. (1998). Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72, 2224-2232. (Pubitemid 28100780)
41. Zhang, F.L., Jia, S.Q., Zheng, S.P., et al. (2011). Celastrol enhances AAV1-mediated gene expression in mice adipose tissues. Gene Ther. 18, 128-134.
42. Zincarelli, C., Soltys, S., Rengo, G., and Rabinowitz, J.E. (2008). Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol. Ther. 16, 1073-1080. (Pubitemid 351737072)